Medicamen Organics Limited (MEDIORG)
Medicamen Organics submitted the Structured Digital Database (SDD) Compliance Certificate for the financial year ended March 31, 2026. The company confirmed full adherence to SEBI (Prohibition of Insider Trading) Regulations, capturing all 19 required events with no non-compliance observed.
Apr 23 2026 16:04:00
Medicamen Organics Limited (MEDIORG)
Medicamen Organics appointed Divya Sharma as Company Secretary, effective April 17, 2026. This appointment reinforces corporate governance and statutory compliance with her decade of experience in manufacturing and IT.
Apr 17 2026 17:04:00
Medicamen Organics Limited
Medicamen Organics appointed Ms. Divya Sharma as Company Secretary & Compliance Officer. The Board also authorized Key Managerial Personnel to determine the materiality of events for stock exchange disclosures, effective from the meeting on April 17, 2026.
Apr 17 2026 16:04:00
Medicamen Organics Limited (MEDIORG)
Medicamen Organics Limited appointed Ms. Divya Sharma as Company Secretary & Compliance Officer, effective April 17, 2026. This appointment, approved by the board, is based on the Nomination and Remuneration Committee's recommendation, enhancing corporate governance.
Apr 17 2026 16:04:00
Medicamen Organics Limited (MEDIORG)
Medicamen Organics announced that Varsha Bansal ceased to be the Company Secretary effective April 16, 2026. This change impacts the company's key managerial personnel structure.
Apr 16 2026 20:04:00
Medicamen Organics Limited (MEDIORG)
Medicamen Organics announces the resignation of Ms. Varsha Bansal as Company Secretary & Compliance Officer, effective April 16, 2026. She served as a Key Managerial Personnel.
Apr 16 2026 18:04:00
Medicamen Organics Limited (MEDIORG)
Medicamen Organics states it is not a 'Large Corporate' as per SEBI guidelines as of March 31, 2026. This means the company is exempt from disclosure and compliance requirements for debt security fund-raising applicable to large entities.
Apr 15 2026 12:04:00
Medicamen Organics Limited (MEDIORG)
Medicamen Organics clarified to the NSE that the recent increase in its share price is solely due to market forces. The company confirmed it has not withheld any material or price-sensitive information.
Apr 13 2026 17:04:00
Medicamen Organics Limited (MEDIORG)
Medicamen Organics EGM approved increasing authorized share capital, preferential issue of up to 20 lakh equity shares to the public, and 11.86 lakh fully convertible warrants to both promoter and public categories. Additionally, it approved converting a loan into 7.14 lakh equity shares for the promoter.
Apr 10 2026 21:04:00
Medicamen Organics Limited (MEDIORG)
Medicamen Organics EGM approved a significant capital restructuring. This includes increasing authorized capital, a preferential issue of 20 lakh equity shares, and issuing 11.86 lakh warrants. Additionally, a loan will be converted into 7.14 lakh equity shares for promoters, strengthening the company's financial base.
Apr 09 2026 19:04:00
Read More